Orbital organoids reach IND: 40 days in microgravity changed a cancer drug's path
Patient-derived glioblastoma cultures spent 40 days on the ISS and returned more uniform than the ground controls. The drug that followed, rebecsinib, sits under an active IND. Auxilium printed a kidney and a liver in orbit; Crew-13 delivered tissue hardware on October 1.